FDA recently approved Mogamulizumab-kpkc, a human monoclonal antibody prescribed for adult patients with mycosis fungoides or Sezary syndrome whose disease condition returns after treatment with at least one prescribed chemotherapy regimen.from Medindia Latest Updates https://ift.tt/2BnMzWN
No comments:
Post a Comment